CD44 and breast cancer: An additional subpopulation of CD44+/CD24+ cells of the BRCA1-mutated basal-A/basal-like breast cancer was sorted using an antibody against CD338 (ABCG2 antigen) and found to be enriched in several stemness markers [23].